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The measurement of mRNA turnover in living cells plays an important role in the search for stable mRNA
constructs for RNA-based therapies. Here we show that automated time-lapse microscopy combined with
micropatterned arrays allows for efficient high-throughput monitoring of fluorescent reporter protein
expression at the single-cell level. The fluorescence time courses after mRNA transfection yield the distri-
bution of individual mRNA expression and degradation rates within a population. We compare mRNA con-
structs with combinations of 5′ and 3′ UTR sequences and find a systematic broadening and shift towards
longer functional half-lives for UTR stabilized mRNA. At the same time the life time distribution of the
destabilized EGFP reporter protein was found to be constant and narrowly distributed. Using mathematical
modeling, we show that mRNA functional life-time predicts the time-integrated protein level, i.e. the area
under the curve (AUC) of mRNA translation. Our approach paves the way for quantitative assessment of
hitherto unexplored mRNA functional life time heterogeneity, possibly predicated on multiple mRNA sec-
ondary structures and its dependence on UTR sequences.Introduction
In recent years, messenger RNA (mRNA) has become increas-
ingly relevant as a new drug entity. As opposed to DNA-based
gene therapeutics, mRNA does not need to be transported
into the nucleus but is directly translated into protein in the
cytoplasm.1,2 This makes mRNA safer in avoiding potential
insertional mutagenesis, an unlikely but existent risk of DNA
gene medicines. As a consequence, mRNA therapeutics are
emerging as promising alternatives for gene and protein
replacement therapies in a broad variety of medical
indications.1–4 However, the strong immunogenicity as well as
the limited stability of conventional mRNA has to be over-
come to further establish its clinical applicability. In particu-
lar, mRNA stability is an essential parameter for envisaged
medical applications because it determines, for example, dos-
ing and the dosing intervals of mRNA drugs.
Several strategies have proven successful both at increas-
ing the stability and reducing the immunogenic responsetriggered by mRNA administered to cells or organisms.
Amongst these is the inclusion of chemically modified nucle-
otides.5 Kormann et al. have shown that the replacement of
only 25% of uridine and cytidine residues by 2-thiouridine
and 5-methyl-cytidine suffices to increase mRNA stability as
well as to reduce the activation of innate immunity triggered
by externally administered mRNA in vitro.3
Also, untranslated regions (UTRs) in mRNAs have been
reported to play a pivotal role in regulating both mRNA stability
and mRNA translation. UTRs are known to influence transla-
tional initiation, elongation, and termination, as well as mRNA
stabilization and intracellular localization through their interac-
tion with RNA binding proteins.6,7 Depending on the specific
motives within the UTR, it can either enhance or decrease
mRNA turnover.8–11 Recently, data on mRNA half-lives and the
corresponding UTR sequences have been published.12,13
One mRNA with a particularly long half-life is the one
transcribed from the human cytochrome b-245 alpha poly-
peptide (CYBA) gene. The CYBA gene comprises specific 5′
and 3′ UTRs. In general, 5′ UTR motives such as upstream
open reading frames (uORFs) or internal ribosomal entry
sites (IRES) are known to be involved in gene regulation, par-
ticularly in translational initiation.14 The 3′ UTRs can com-
prise even more regulatory functions than the 5′ UTRs, some
of them even hindering mRNA translation.15 While no regula-
tory motives are known for the CYBA 5′ UTR unit, the CYBA 3′
UTR contains two of them. Firstly, the polyadenylation signal
(PAS), which interacts with the cytoplasmic polyadenylationp, 2015, 15, 3561–3571 | 3561






























































































View Article Onlineelement binding protein (CPEB), as well as with the cleavage
and polyadenylation signaling factor (CPSF).11 CPEB is
responsible for the prolongation of the poly-A tail in the cyto-
plasm, whereas CPSF primes the pre-mRNA through cleavage
at a specific site for the upcoming addition of poly-A.11,15 As
a second regulatory motif, the CYBA 3′ UTR contains the insu-
lin 3′ UTR stability element (INS_SCE). The INS_SCE sequence
has been shown to bind to the polypyrimidine tract binding
protein (PTB) under reducing conditions, increasing the
mRNA half-life of insulin.16 UTRs of CYBA are shown in
Table S2.† Another important feature influencing mRNA
translation efficiency is the poly A-tail, which is located on
the 3′ end. It has been shown that a prolongation of the
poly A-tail to 120 nucleotides has beneficial effects on pro-
tein expression, assumingly because of the protective effect
of longer poly A-tails against mRNA degradation.17 In con-
trast to long poly A-tails, mRNAs with poly A-tails shorter
than 50 nucleotides are claimed not to be translated at all.11,18
Hence, in mRNA therapy, recombinant mRNA constructs are
advantageously furnished with a poly A-tail of 120 nucleotides.
Degradation of most mRNAs in eukaryotic cells begins with 3′
to 5′ exonucleolytic deadenylation, resulting in removal of most
of the poly A-tail. Subsequently, two major pathways that are
responsible for the degradation of the rest of the mRNA body
are known to come into play. On the one hand, the 5′ end is
decapped by the Dcp1/Dcp2 complex, followed by 5′–3′ exo-
nucleolytic degradation that is catalyzed by Xrn1p. On the other
hand, the exosome enables 3′–5′ exoribonucleolytic degradation
with the 5′ cap being retained.19 Moreover, it is known that the
5′ cap interaction with the 3′ poly A-tail results in circular forms
of the mRNA. It is assumed that the circular shape of the mRNA
increases the initiation rate of ribosomes and also protects
mRNA against degradation.20
We were interested in whether the reported long half-life
of natural CYBA mRNA can be conferred to a foreign mRNA
by virtue of flanking its coding sequence with combinations
of CYBA 5′- and 3′-UTRs. So far, mRNA stability and turnover
have been measured by a variety of approaches including
metabolic labelling, mass spectrometry, quantitative real-time
reverse transcription polymerase chain reaction (qRT-PCR),
microarrays, or fluorescence labelling techniques for imaging
mRNA inside cells.17,21–26 Most of these are ensemble mea-
surements and data represent mean of all cells without tak-
ing into account the fluctuations in the expression amounts
(high vs. low) or timing of expression (early or late). Hence,
population measurements exhibit an averaged response and
are of limited use for computational analysis of the underly-
ing biochemical network. In contrast, single-cell distribu-
tion functions provide additional information about the
heterogeneity in transfection experiments.
Recently, we have shown that single-cell analysis of mRNA
transfection time-lapse movies is capable of assessing indi-
vidual expression time-courses, yielding mRNA decay rates at
the single-cell level.27 Furthermore, we have reported on the
use of regular micropatterns to position cells on a regular
grid of adhesion sites.28 Hence, we were interested in3562 | Lab Chip, 2015, 15, 3561–3571applying this single-cell micro-array technology to screen and
compare different mRNA constructs in a more rapid and
standardized format than single-cell studies in diluted cul-
ture can do. To address this question, we have chosen the
coding sequence of destabilized enhanced green fluorescence
protein (d2EGFP) to artificially shorten the life cycle of the
reporter protein inside the cell.29 The combinations included
insertion of the respective CYBA UTRs at 5′ or 3′ ends, respec-
tively, at both 5′- and 3′ ends, at the 5′ end combined with two
repeats of the 3′ UTR at the 3′ end, or two repeats of 3′ UTR
without 5′ UTR. All of these compared to a control construct
without UTRs. Protein and mRNA functional life times and the
expression rates from each of the compared transcripts were
assessed using both the single-cell approach and population
based methods like flow cytometry, fluorescence microscopy
and qRT-PCR. As expression of d2EGFP is a direct readout of
the functionality of d2EGFP stable non-immunogenic mRNA
(SNIM® RNA), expression kinetics were used to determine the
“functional” half-life of d2EGFP SNIM® RNA.
Results
Fluorescence microscopy and analysis via flow cytometry (FC)
To evaluate the effect of different UTR combinations on
transgene expression kinetics, two different cells lines were
transfected using Lipofectamine™ 2000 with different
d2EGFP mRNA constructs containing a 5′ UTR alone, a 3′
UTR, 5′ + 3′ UTR, two copies of 3′ UTR and 5′ + 2 × 3′ UTR. A
schematic representation of the building blocks of all con-
structs can be seen in Fig. 1A.
At different time points through three days post-transfec-
tion, d2EGFP expression was quantified using FC. An exem-
plary dot plot for t = 24 h, illustrating d2EGFP expression levels
of live A549 cells, is shown in Fig. 1C (see Fig. S4B† for corre-
sponding Huh7 data). In addition, we imaged the cells using
fluorescence microscopy (see Fig. 1B and D and Fig. S4A and
C†). Comparable transfection efficiencies for all mRNA con-
structs were confirmed 24 hours post transfection (Fig. 1B and
S5A†). Thereby, we can rule out differential transfer efficiencies
to be a causal factor for the observed differences in expression
kinetics. Based on fluorescence microscopy images, we
detected a drastic reduction of d2EGFP expression for all con-
structs at 48 h post-transfection (see Fig. 1B and D, S4A and
C†). However, higher d2EGFP expression levels with respect to
the control were found for all UTR-stabilized mRNAs. More
specifically, mRNA constructs containing 3′ UTRs seemed to
enhance expression more than constructs without 3′ UTRs. We
observed this for A549 and Huh7 cells (see Fig. 1 and S4,†
respectively). At time points later than 48 h, this effect was even
more pronounced (data not shown). In Fig. 2A and B, the time-
courses of the mean fluorescence intensities (MFI) as deter-
mined by FC are shown for all constructs in both cell types.
Also here, all UTR-containing mRNA constructs showed
higher MFI values than the control construct in both cell
lines at all time points. Taken together, our fluorescence
microscopy and FC data suggest that mRNA moleculesThis journal is © The Royal Society of Chemistry 2015
Fig. 1 Fluorescence microscopy and flow cytometry data of A549
cells. (A) Schematic illustration of therapeutic mRNA, consisting of a 5′
cap, a 5′ UTR, an encoding region, a 3′ UTR and a poly-A tail. (B) Fluo-
rescence microscopy pictures taken with 4× magnification (JULY™) at
24 h post-transfection. All constructs showed improved protein
expression levels as compared to the control. (C) The percentage of
d2EGFP positive cells as determined by FC is similar for all constructs.
Propidium iodide was used to detect dead cells. The applied gates
ensured exclusion of dead cells and untransfected cells. (D) At 48 h
post transfection, sustained protein expression was higher for the sta-
bilized constructs as compared to the control.
Fig. 2 Time-courses of protein expression as determined by FC for
A549 cells (A) and Huh7 cells (B). Mean fluorescence intensities
normalized to the control are plotted versus time in a log-linear plot.
With increasing time post transfection, the elevated protein expression
levels of the stabilized constructs become more and more evident.
The green, red and blue bars correspond to the control/5′ UTR/3′ UTR
constructs, respectively. The purple, orange and grey bars correspond
to the constructs that are shown on the bottom of the figure.






























































































View Article Onlinefurnished with CYBA UTRs show persistent d2EGFP expres-
sion for more than 24 hours.Quantitative real-time PCR
We conducted qRT-PCR measurements as an additional
approach to determine the physical mRNA half-life of the dif-
ferent constructs. Binding of our selected primers to d2EGFP
occurred 600 nt downstream of the start codon. Hence, mea-
surements of physical mRNA half-life comprise both intact
mRNAs and those which have either been decapped but not
yet degraded or both decapped and degraded up to base 599.This journal is © The Royal Society of Chemistry 2015It also includes mRNA that has been removed from the trans-
lational pool and stored in P-bodies.30–33 Only intact mRNAs
yield d2EGFP protein, while decapped and/or partially
degraded transcripts and those in P-bodies do not lead to
any expression. Determination of physical mRNA half-lives
did not reveal any significant life time prolongation by the
UTRs compared to the control in the A549 and Huh7 cells
(see ESI† S5A and B, respectively). Interestingly, we observed
a decrease in mRNA physical half-lives for 5′, 3′, 5′ + 2 × 3′
and 2 × 3′ UTR constructs in both cell lines.
Single-cell expression arrays
We fabricated microstructured, cell-adhesive substrates as
shown in Fig. 3A and B as a platform for single-cell time-
lapse microscopy.Lab Chip, 2015, 15, 3561–3571 | 3563
Fig. 3 Microstructured multi-channel slides for parallel single-cell
assays to test differently stabilized mRNA constructs. (A) Cell-adhesive,
microstructured protein patterns with cell-repellent PEG areas in
between allow ordered cell arrangement. Fluorescently labeled fibro-
nectin was used to visualize the micropattern. (B) Fluorescent A549
cells adhering to fibronectin patterns inside a microchannel (three
hours after seeding). (C) Schematic drawing of mRNA lipofection (on
the left) and reaction scheme underlying our analytical solution (on the
right). (D) Exemplary time-courses of mRNA-mediated d2EGFP expres-
sion in A549 cells. Red lines are representative fits to the theoretical
translation model.






























































































View Article OnlineThe rectangular squares are functionalized with the extra-
cellular matrix protein fibronectin, while the surrounding
dark area is passivated with cell repellent PLL-g-PEG. Cells
were seeded at an appropriately dilute cell density such that
after about three hours cells adhered to the rectangular
squares. This cellular self-organization process has been
studied in detail before.28 The size of the squares was 30 μm
for optimal filling with single cells. The distance between the
squares was just big enough (60 μm) to minimize bridging
effects of cells adhering to more than one square at the same
time. Time-lapse fluorescence microscopy and automated
image analysis of the fluorescence signal per square yields
hundreds of individual time-courses. A typical set of back-
ground corrected raw data is shown in Fig. 3D. The red lines
represent exemplary fits to the mathematical expression for
mRNA translation (see also Materials and Methods section).
Data were analyzed as described recently27 by fitting each
time-course with the analytical solution for mRNA-induced
protein expression,3564 | Lab Chip, 2015, 15, 3561–3571(1)
using IgorPro software. Here, G denotes the amount of pro-
tein, K is the expression rate, δ is the degradation rate of
functional mRNA, and β is the degradation rate of the
reporter protein d2EGFP. The expression rate K = m0 × kTL is
the product of the initial amount of mRNA molecules inside
the cell (m0) and the translation rate kTL. The time-course
that is described by eqn (1) will be discussed in detail in
below section “master curves of protein expression”.In vitro transfection on cell arrays
In a typical experiment, cells were allowed to adhere to the
micropatterns for three hours before transfection. Each of
the six microchannels was filled with a different lipoplex
solution, containing one of the constructs of interest. In ini-
tial experiments, we compared two different, commercially
available transfection reagents (namely Lipofectamine™ 2000
and DOGTOR). We found higher transfection efficiencies for
Lipofectamine™ 2000 than for DOGTOR (see Fig. S1†).
Because we additionally obtained high cell viability rates of
above 80% with Lipofectamine™ 2000 (data not shown), all
further transfection experiments were conducted using
Lipofectamine™ 2000. As mRNA-mediated protein expression
starts shortly after transfection, incubation time was kept to
a minimum. Accordingly, the ratio between mRNA dosage
and incubation time was adjusted to achieve high transfec-
tion efficiencies (see also Fig. S1†) and negligible toxic effects
caused by over-expression of the reporter protein. At an
mRNA dose of 5 pg per cell, an incubation time of one hour
was found to be optimal.Expression rates
All results for the two cell types are based on four indepen-
dent measurements under the same experimental conditions.
Time-lapse data of about thousand A549 cells and thousand
Huh7 cells have been analyzed. The distributions of the
obtained expression rates K are shown in Fig. 4A and the cor-
responding mean values can be seen in Fig. 4D.
Both the mean expression rates and the shape of their dis-
tributions were found to be rather similar for the different
constructs.mRNA functional half-lives
We converted the fitted mRNA-degradation rates δ into
mRNA functional half-lives according to
(2)
Fig. 4B shows the functional half-life distributions of the
examined mRNA constructs in A549 and Huh7 cells, respec-
tively. Here, it becomes evident that for constructs withThis journal is © The Royal Society of Chemistry 2015
Fig. 4 Distributions of expression rates K, mRNA functional life times, and d2EGFP life times and corresponding mean values with schematic
representations of the constructs. (A) Distributions of expression rate K, which is the product of the initial number of mRNA molecules and the
translation rates. The fact that the distributions are similarly shaped indicates that the transfection kinetics and the translation rates are very
similar. (B) The distributions of the mRNA functional half-lives show great variations in their broadness. As a guide to the eye, dotted lines indicate
the mean half-life of the control. (C) Distributions of d2EGFP half-lives. As expected, the distributions of the different constructs are similarly
shaped and show comparable mean values. As a guide to the eye, the overall mean half-life of d2EGFP based on all measured half-lives is shown
as a dotted line. (D) Mean values and the corresponding standard deviations (std) of the fitted rates. Although the control construct yields high
mean K values in both cell types, the short mRNA functional half-life of this construct leads to small AUC values as compared to the stabilized con-
structs. This can be seen in Fig. 6. Schematic representations of the constructs can be seen on the right hand side. All constructs have the same 5′
cap and a poly A-tail. Data from 895 single A549 and 1355 Huh7 cells were analysed.






























































































View Article OnlineUTRs, both mean functional half-life and broadness of the
underlying distribution increase as compared to the reference
construct without UTRs.
An overview of all determined functional half-lives is given
in Fig. 4D. Both for A549 and for Huh7 cells, we found longer
functional half-lives for mRNAs stabilized by UTR elements
compared to the control construct (5.8 hours for A549 cells
and to 7.8 hours for Huh7 cells) that does not contain any
stabilizing UTR. The functional life time prolonging effect
was more pronounced in A549 cells.This journal is © The Royal Society of Chemistry 2015Protein half-lives
The distributions of protein (d2EGFP) degradation life times
are presented in Fig. 4C. As expected, the half-lives of the
expressed protein do not vary for the different mRNA con-
structs. The determined mean life times range from 4.2 to
4.9 hours for A549 cells and from 5.6 to 8.5 hours for Huh7
cells as shown in Fig. 4D. The coefficients of variation are
about 0.29 (A549) and 0.45 (Huh7) and hence are significantly
smaller than the coefficient of variation of up to 0.6 that weLab Chip, 2015, 15, 3561–3571 | 3565






























































































View Article Onlinefound for the distribution on mRNA functional life times. As a
control, we also measured the half-lives in an alternative
approach, where translation was inhibited by addition of cyclo-
heximide at a given time point, t0, after transfection (see Fig.
S3†). In this case, protein expression is induced for a while and
then stopped. The exponential decay in fluorescence after inhi-
bition yields protein life times. These half-lives were found to be
smaller by a factor of about two, compared to the above experi-
ments without inhibition. In both experiments, however, the rel-
ative ratios of the protein life times in Huh7 cells as compared
to those in A549 cells is the same.
Master curves of protein expression
The features of mRNA induced protein expression become
evident in the so-called master curve of protein expression as
depicted in Fig. 5A (A549) and B (Huh7).
The master curve is the population average of the onset-
time corrected single-cell traces, i.e. all onset-times were
shifted to time point zero. Fluorescence intensities were
converted into actual numbers of d2EGFP as described before
in reference.27 The superior properties of the 3′ and the 5′ +
3′ UTR mRNA constructs are illustrated in the master curve
plot. These constructs showed the shallowest decrease in pro-
tein expression with time and hence the longest functional
half-lives in addition with higher protein expression values as
compared to the other constructs.
Area under the curve (AUC)
In pharmacokinetics, the concentration-time curve of a drug
in the blood circulation is known as the “area under the
curve” (AUC) which is a measure of the bio-availability of a
drug. Here, we use the term for the cumulative time-dose of3566 | Lab Chip, 2015, 15, 3561–3571
Fig. 5 Master curves of the different constructs. Population averages
of A549 (A) and Huh7 (B) cells with the onset-time shifted to zero. The
green, red, and blue curves correspond to the control/5′ UTR/3′ UTR
constructs, respectively. The black curves correspond to the
constructs on the right hand side.the protein that is encoded by the mRNA. In this respect, the
AUC simultaneously quantifies the translational efficiency
and the stability and hence the overall efficacy of a chosen
mRNA construct. Given the biochemical rate model (see
Fig. 3A), the AUC can be explicitly calculated (see also Fig. S2†):
AUC = 0.48 × m0 × kTL × τmRNA × τd2EGFP (3)
Hence an optimal therapeutic mRNA construct should
desirably have both long mRNA function half-life, τmRNA, as
well as a protein half-life, τd2EGFP, and high translational effi-
ciency, kTL. In addition, the transfer efficiency which deter-
mines the initial amount of therapeutic mRNA, m0, is directly
proportional to the AUC. An illustrative explanation for the the-
oretical time-course of protein expression and the calculated
AUC can be seen in Fig. 6A.
If there was no protein degradation (β = 0), the amount of
protein inside a cell would run into a steady state level as a
consequence of a balanced flux of mRNA translation and
mRNA degradation. In this case, the expression dynamics fol-
lows The same would be true in an analogous
manner for the case where δ was equal to zero. The superposi-
tion of this with the permanent, exponential decay of the
d2EGFP protein (following e−βt) results in the characteristic
shape of the AUC as shown in Fig. 6A. Fig. 6B and C show the
overall mean relative AUCs as well as the “per-experiment” rel-
ative AUCs normalized to the mean AUC of the control, the
latter being the AUC of protein expression after transfection
with the control construct. In both cell types, we find the
highest relative AUCs for the 3′ UTR- and the 5′ + 3′ UTR-
stabilized construct. This is consistent with the observed long
functional half-lives for these constructs, because they con-
tribute to the AUC as seen in eqn (3). The detailed, single-cell
AUC distributions can be found in Fig. S2 of the ESI.†
Functional life time prolongation factor
The functional life time prolongation factors for A549 and
Huh7 cells are shown in Fig. 6D and E, respectively. As
expected, all UTR-flanked constructs yield functional life time
prolongation factors higher than one, meaning that the inser-
tion of UTRs at either end causes mRNA stabilization. How-
ever, the 3′ UTR mRNA construct shows longer mRNA func-
tional life times than the 2 × 3′ UTR construct. Similarly, the
5′ + 3′ UTR construct is more persistent than the 5′ + 2 × 3′
construct. These results hold true for both cell types. Interest-
ingly, the stabilizing effects are significantly more pro-
nounced in A549 cells than in Huh7 cells in all cases.
Discussion
Determination of mRNA functional stability and its expres-
sion are two major factors to be considered when it comes to
developing new mRNA therapeutics. Here, we used different
combinations of UTRs, a 5′ UTR, 3′ UTR, a 5′ + 3′ UTR, 5′ + 2 ×This journal is © The Royal Society of Chemistry 2015
Fig. 6 AUC and mRNA functional life time prolongation factors of the
different constructs. (A) Schematic representation of the AUC to
illustrate the interplay between mRNA translation and degradation of
mRNA and protein. (B) and (C) AUC of the different constructs as
analysed for t → ∞. Crosses show relative AUCs of different
experiments, the bars correspond to the mean of all single-cell AUCs.
(D) and (E) mRNA functional life time prolongation factors. All modifi-
cations result in prolonged mRNA functional life times as compared to
the control. Similar trends are observed in A549 (D) and Huh7 (E) cells.
Error bars in (D) and (E) indicate standard deviation.






























































































View Article Online3′ UTR, and two copies 3′ UTR to improve mRNA in terms of
functional stability and its expression. The AUC of the d2EGFP
time-course is also evaluated, because the total protein expres-
sion is relevant for a sustained therapeutic effect. In order to
get detailed time-resolved data and monitor protein expression
dynamics at the single-cell level, we used microstructured
single-cell arrays for parallel, quantitative measurements of
mRNA stability and translational efficiency. The regular
arrangement of cells guaranteed reproducible microenviron-
ments and enabled fast and automated image-analysis, which
are prerequisites for comparative, high-throughput single-cell
studies. The approach allows the determination of distribution
functions for (i) protein half-life, (ii) expression rates, and (iii)
functional mRNA half-life.
In both A549 and Huh7 cells, mean protein half-lives of
d2EGFP were narrowly distributed and independent of the
UTR sequence. The calculated half-life values of 4.5 hours for
A549 cells and 7.4 hours for Huh7 cells could be attributed to
cell type specific differences between the compared cell lines.
Such cell specific differences in d2EGFP half-life have beenThis journal is © The Royal Society of Chemistry 2015published previously. A study in NIH3T3 cells using a similar
imaging cytometry approach recorded a half-life of 2.8 h
within a measurement window of 12 hours.34 An even shorter
half-life of less than two hours has been reported for CHO
cells by Li et al.35 Here, protein degradation was measured by
Western blotting and flow cytometry for three hours only.
To validate our findings from single-cell data analysis, we
additionally determined d2EGFP life times in direct measure-
ments using cycloheximide (see Fig. S3†). We found shorter
life times as compared to the values observed from single-cell
data analysis. This might be due to the fact that in single-cell
data analysis, a constant initial number of mRNA molecules
was assumed as part of the combined expression rate K = m0
× kTL (see eqn (1)). However, regardless of the fact that cells
have been washed after one hour incubation time, it is still
likely that the number of mRNA molecules is not constant
from the start of observation. As a consequence, mRNA mole-
cules that are available for translation later on, leading to
protein expression, might result in longer half-life values
obtained from single-cell expression time-course fitting.
When we compare the mean half-life determined for A549
cells with the mean half-life determined for Huh7 cells, we
find the same ratio of roughly 1.64 for both measurement
methods. Also, even a possible systematic over-estimation of
mRNA and protein half-lives does not change the qualitative
order of the mRNA performance as determined by us.
The expression rate depends on the initial number of
mRNA molecules, m0, as well as on the translation rate KTL.
Note that the number of successfully delivered mRNA mole-
cules varies due to the intrinsic stochasticity of the delivery
process. The mean number of mRNA molecules, however, is
expected to be the same, since the transfection protocol has
scrupulously been kept up in all experiments. In contrast, the
translational activity (KTL) of the various UTR constructs
might vary. Still, the fact that the distributions as well as the
mean values of the expression rate K are rather similar for all
constructs (see Fig. 4A and D) indicates that the translation
rate is merely influenced by the inserted UTRs.
The parameter of highest interest is the mRNA functional
half-life. Here, we compared functional mRNA half-life to
physical mRNA half-life. Our results with single-cell transfec-
tion studies suggest that any insertion of 5′ or 3′ UTRs into
the mRNA sequence increases its functional half-life which
was observed for all modifications tested in this study (see
Fig. 4 and 6) as measured by fluorescence microscopic imag-
ing and FC (see Fig. 1 and 2). In contrast to the functional
mRNA half-life, the physical mRNA half-life determined by
qRT-PCR showed a decrease in mRNA stability for 5′, 3′, 5′ +
2 × 3′ and 2 × 3′ UTR in both cell lines (see Fig. S5A and B†).
One major difference is that the physical half-life as mea-
sured by qPCR does not reflect the translational (“func-
tional”) productivity of a given mRNA construct. qPCR as
used here merely quantifies the physical presence of an
mRNA fragment and is inappropriate to predict the utility of
an mRNA construct in a therapeutic application. Similar find-
ings have been reported by Gallie et al.36 In contrast, theLab Chip, 2015, 15, 3561–3571 | 3567






























































































View Article Onlinefunctional half-life as measured here is a function of the
translational capacity of an mRNA, determines the amount of
total protein produced (Area Under the Curve) and predicts
the utility of an mRNA construct for a therapeutic applica-
tion. For a therapeutic mRNA, it can be imperative that the
molecule is functional for as long or as short as possible and
yields a maximum or a minimum of protein. Furthermore,
the heterogenic distribution of the functional half-lives
points out the importance of single-cell measurement tech-
niques, because these effects are obscured in ensemble mea-
surements (see Fig. 2, 4 and S5A† and B). An interesting con-
clusion from the observed discrepancy of physical and
functional half-lives is that obviously cells make more pro-
ductive use of moderate amounts of mRNA than of the initial
high amounts present at the early time points after transfec-
tion. In fact, the impact of the UTRs examined here on mRNA
productivity become increasingly evident at the later time
points after transfection.
Interestingly, a positive effect on protein expression was
observed for 5′ UTR alone, although so far, no known motif
in the CYBA 5′ UTR has been discovered. For the first time,
we could show that CYBA UTRs at either end suffice to
increase both peak and persistence of protein expression in
both cell lines. These findings are consistent with publica-
tions claiming individual or synergistic behaviour of 5′ UTRs
and 3′ UTRs.15 In contrast to Holtkamp et al.,17 no additional
increase in protein expression or mRNA functional stability
could be observed with two sequential copies of the 3′ UTR
as compared to one single 3′ UTR (see Fig. 4). Conversely, it
even resulted in shorter functional life times both for 5′ + 3′
versus 5′ + 2 × 3′ UTR insertion and for 3′ versus 2 × 3′ UTR
insertion. This might be due to the fact that a different type
of cells (namely dendritic cells) was used in the study by
Holtkamp et al.17 Similar cell type-specific effects have been
reported for hepatocytes, too.37 Another contributing factor
affecting mRNA functional stability might be the secondary
structure of the different mRNAs. Such effects of mRNA sec-
ondary structure in regulating gene expression have been
reported before.38,39
Important structural characteristics together with their
minimum free energy for the mRNA constructs used in the
current study are summarized in Table S1.† The persistent
protein expression of the 5′ + 3′ UTR stabilized construct
could be due to binding of the 5′ to the 3′ end, which facili-
tates circularization of the mRNA.20 Because we could not
find any stable secondary structures within the 5′ UTR, we
assume that this feature enables an early expression onset.40
In contrast, we identified secondary structures within the 3′
UTRs. These might protect the mRNA from the 3′–5′ degrada-
tion pathway. Two 3′ UTRs showed even more secondary
structures (two hairpins) with the best minimum free energy,
indicating more persistent expression. Taken together, these
findings could be the explanation for the inferior onset
expression of the 2 × 3′ UTR compared to the 5′ UTR and the
persistent expression at later time points of mRNA constructs
containing 3′ UTRs.3568 | Lab Chip, 2015, 15, 3561–3571In accordance with protein half-lives, longer functional
half-life values were obtained for mRNAs stabilized with
UTRs. This was observed in both cell lines with cell-specific
differences most likely affecting the absolute values. In A549
cells, mRNA functional half-lives for the constructs with
UTRs ranged from 13.0 h to 23.0 h as compared to 5.8 h for
the control. In Huh7 cells, functional half-lives from 9.9 h to
13.6 h were measured for UTR-containing constructs, as
opposed to a functional half-life of 7.8 h for the control
mRNA. The functional half-life of the 3′ UTR-flanked mRNA
in A549 cells is in good agreement with mRNA life times of
similarly stabilized mRNAs that were reported previously.17,27
The fact that functional stability and decay kinetics of mRNA
and protein differ in different cell types is most likely due to
differences in the complex networks of interactions between
mRNA and proteins which are very likely to be cell-type
dependent.
Taken together, our results in both A549 and Huh7 cells,
independent of the analysis method (FC or single-cell analy-
sis), suggest that sustained, high levels of protein expression
can be induced by CYBA UTR flanked mRNA. The choice of
UTR combination depends on the need of the experiment of
application. Where persistent protein expression with
reduced mRNA decay is desired, mRNA flanked with a 3′ UTR
alone might serve the purpose. However, the combination of
5′ + 3′ UTR results in additional desirable features of early
onset, high peak and cumulative protein expression.
Our study demonstrates that micro-array based single-cell
analysis of mRNA-induced protein expression is a means to
characterize and improve kinetic properties of mRNA con-
structs. Using automated time-lapse microscopy and auto-
mated image analysis, we were able to assess the intracellular
bioavailability of different mRNA constructs at the single-cell
level in a highly parallel format. The micro-arrays provide a
standardized platform to transfect arrayed cells at high num-
ber density on a chip and with defined boundary conditions
such as the cell area. This allows to acquire single-cell time
traces from equally treated cells and hence a more reliable
basis to identify sequences yielding sustained protein expres-
sion. We found prolonged persistence of protein expression
for constructs stabilized by UTR insertions using a single-cell
model and FC analysis in two cell types. This finding is
desired in case of developing mRNA therapeutics. Messenger
RNA constructs with persistent protein expression over a
period of time (AUC) is desirable and allows proper reduced
dosing into a patient with a final therapeutic outcome. We
hope that our study helps to further refine strategies for the




Destabilized Enhanced Green Fluorescent Protein (d2EGFP)
was excised from pd2EGFP-N1 (Clontech) and cloned in
pVAXA120 (ref. 3) to generate pVAXA120-d2EGFP. Based onThis journal is © The Royal Society of Chemistry 2015






























































































View Article Onlinepreviously published data with respect to mRNA stability,
preselected 5′ and 3′ UTR sequences of CYBA gene were syn-
thesized by Eurofins MWG (Germany) and cloned upstream
(5′ UTR) and/or downstream (3′ UTR or 2 × 3′ UTR) of
d2EGFP in pVAXA120-d2EGFP, thereby generating the con-
structs with respective UTR combinations.mRNA production
To generate in vitro transcribed mRNA (IVT mRNA), plasmids
were linearized downstream of the poly-A tail by NotI diges-
tion and purified by chloroform extraction and ethanol pre-
cipitation. Purified linear plasmids were used as template for
in vitro transcription using RiboMax Large Scale RNA produc-
tion System-T7 (Promega, Germany). Anti-Reverse Cap Analog
(ARCA) was added to the reaction mix to generate 5′ capped
mRNA. Additionally for the production of SNIM® RNAs,
chemically modified nucleotides namely methyl-CTP and
thio-UTP (Jena Bioscience, Germany) were added to a final
concentration of ATP : CTP : UTP :methyl-CTP : thio-UTP :GTP
of 7.57 mM : 5.68 mM : 5.68 mM : 1.89 mM : 1.89 mM : 1.21
mM. The complete IVT mix was incubated at 37 °C for 2
hours followed by a DNA disgestion with DNaseI for 20
minutes at 37 °C. RNA was precipitated with ammonium ace-
tate (final concentration 2.5 M) and washed with 70% EtOH.
The washing step was performed twice. Finally, the RNA pel-
let was re-suspended in RNAse-free water. All mRNAs were
verified on 1% agarose gels. A schematic representation of an
exemplary mRNA construct can be seen in Fig. 1A. The exact
sequences of the UTRs are given in the ESI† (Table S1).Flow cytometry (FC)
The experimental set-up looks as follows: 20 000 cells in 150
μl medium were seeded per well in 96-well plates and trans-
fected 24 hours post-seeding. Cells were transfected at a dose
of 5 pg mRNA per cell using the commercial transfection
reagent Lipofectamine™ 2000. Complexes were prepared at a
ratio of 2.5 μl Lipofectamine™ 2000 per 1 μg mRNA. For the
formation of lipoplexes, Lipofectamine™ 2000 and mRNA
were diluted separately in OptiMEM transfection medium in
a total volume of 50 μl, each. These mixtures were incubated
at room temperature for 5 minutes. The mRNA solution was
then mixed with the Lipofectamine™ 2000 solution, followed
by another 20 minutes of incubation at room temperature.
After incubation, 900 μl of OptiMEM were added to the
lipoplex solution. Finally, 50 μl of the complex solution were
added to the cells and incubated for 1 hour. For every mRNA
construct, biological triplicates were prepared. After incuba-
tion, the lipoplex-solution was discarded and fresh 150 μl
medium was added to each well. d2EGFP expression was
measured after 8, 24, 36, 48, 60 and 72 hours using FC. Fluo-
rescence microscopy images were taken at each of these time
points. For FC measurements, the cell culture medium was
discarded and the cells were washed with 1× DPBS (Gibco Life
Technology). Subsequently, 20 μl of TrypLE Express (GibcoThis journal is © The Royal Society of Chemistry 2015Life Technology) were added per well and incubated for 5
min at 37 °C. The reaction was neutralized by adding 80 μl
1 × PBS, supplemented with 2% FBS. Cells were mixed by
pipetting and were transferred into a 96 well plate appropri-
ate for flow cytometric measurements. Finally, 5 μl of
Propidium iodide (final concentration 1 μg ml−1) were added
per well and measured with Attune Auto Sampler (Applied
Biosystems). Please note that fluorescence images were taken
prior to FC analysis with a JULY™ microscope.
Quantitative real-time PCR
A qRT-PCR analysis was used to determine the d2EGFP
mRNA amount at time intervals of 4, 8, 24, 36, 48, 60 and 72
hours in A549 and Huh7 cells. Additionally, the mRNA
expression kinetic itself was used to calculate the mRNA half-
life of each UTR. Here, the cells were transfected similarly to
the protocol described above (see FC). A cell density of
200 000 cells per well was found to be sufficient for RNA iso-
lation. RNA isolation was performed according to the manu-
facturer's protocol using NucleoSpin RNA (Macherey Nagel).
The isolated total RNA was examined in RNA concentration
and quality by spectrophotometric measurements and gel
analysis. Further, 0.5 μg of the total RNA of each UTR con-
structs and the control were used for cDNA synthesis using
Oligo(dT)s from First Strand cDNA Synthesis Kit (Thermo Sci-
entific). Equivalent amounts of cDNA (diluted 1 : 50) were
tested with 125 nM of each d2EGFP-Primer (forward Primer:
5′-CAA CCA CTA CCT GAG CAC CC-3′; reverse Primer:5′-GTC
CAT GCC GAG AGT GAT CC-3′) using SsoAdvanced™ Univer-
sal SYBR® Green Supermix (BioRad). As a standard for the
absolute quantification, pure d2EGFP mRNA produced by
IVT was used for synthesis of cDNA. Absolute mRNA quantifi-
cation was performed on a Lightcycler 96 device (Roche).
Surface patterning and sample preparation
Microstructured surfaces were produced by selective oxygen
plasma treatment (Femto Diener, 40 W for 3 min) on a top as
substrate (ibidi GmbH) with subsequent passivation. Selectiv-
ity was achieved using a polydimethylsiloxane (PDMS) stamp
(cast from a master produced by photolithography) as a
mask. The parts exposed to plasma were passivated by incu-
bation for 30 min with PLLĲ20k)-gĲ3.5)-PEGĲ2k) at a con-
centration of 1 mg ml−1 in aqueous buffer (10 mM HEPES pH
7.4 and 150 mM NaCl). Thereafter, the samples were rinsed
with PBS and the PDMS stamps were removed. The foils were
then fixed to adhesive six-channel slides (sticky μ-slide VI).
Each channel was filled with a solution of 50 μg ml−1 fibro-
nectin in PBS for one hour to render the remaining sectors
cell-adhesive. Probes were thoroughly rinsed with PBS three
times. The samples were stored in cell medium at room
temperature before cell seeding. For this study, square
adhesion sites of 30 μm × 30 μm were used because this
size turned out to be reasonable for single-cell adhesion of
A549 as well as Huh7 cells. Cells were seeded at a density
of 10 000 cells per channel so that roughly one cell couldLab Chip, 2015, 15, 3561–3571 | 3569






























































































View Article Onlineadhere on each cell-adhesive island. To obtain fluorescent
micropatterns as shown in Fig. 3A, a mixture of 20 μg ml−1
fibronectin and 30 μg ml−1 fibrinogen conjugated with
Alexa Fluor 488 was used.Materials
FBS, Leibovitz's L-15 Medium (Gibco), Lipofectamine™ 2000,
and OptiMEM (Gibco) were purchased from Invitrogen, Ger-
many. Sterile PBS was prepared in-house. Ham's F-12K,
DMEM, and Trypsin-EDTA were purchased from c.c.pro
GmbH, Germany. Channel slides were purchased from ibidi,
Germany. Fibronectin was purchased from Yo Proteins, Swe-
den. PLL-g-PEG was purchased from SuSoS AG, Switzerland.
Alexa Fluor 488 was purchased from Life Technologies, Ger-
many. The plasmid pd2EGFP-N1 was purchased from BD Bio-
sciences Clontech, Germany.Cell culture
A human alveolar adenocarcinoma cell line (A549, ATCC
CCL-185) was grown in Ham's F12K medium supplemented
with 10% FBS. A human hepatoma epithelial cell line (Huh7,
JCRB0403, JCRB Cell Bank, Japan) was cultured in DMEM
medium, supplemented with 10% fetal bovine serum. All cell
lines were grown in a humidified atmosphere at 5% CO2
level.In vitro transfection
Three hours prior to transfection, 10 000 cells per channel
were seeded in a 6-channel slide. Cells were transfected at a
dose of 5 pg mRNA per cell using the commercial transfec-
tion reagent Lipofectamine™ 2000 at a ratio of 2.5 μl
Lipofectamine™ 2000 per 1 μg mRNA. The complex forma-
tion was prepared as follows: Lipofectamine™ 2000 and
mRNA were separately diluted in OptiMEM transfection
medium to add up to a total volume of 45 μl, each. These
mixtures were incubated at room temperature for 5 minutes.
The Lipofectamine™ 2000 solution was then mixed with the
mRNA solution, followed by another 20 minutes of incuba-
tion at room temperature. Please note that the microchannels
were never empty during all subsequent rinsing steps: imme-
diately before transfection, the cells were washed with PBS.
Finally, the lipoplex solutions containing different mRNAs
constructs were filled into the six channels. All five different
mRNA constructs plus the reference construct could thus be
measured under the same experimental conditions. The cells
were incubated in a total transfection volume of 90 μl at 37
°C (5% CO2 level) for one hour. The transfection medium
was thereafter removed and the cells were washed with PBS.
Subsequently, the cells were re-incubated with Leibovitz's
L-15 Medium containing 10% FBS. A drop of anti-evaporation
oil (ibidi GmbH, Germany) was added on top of each
medium reservoir before microscopic monitoring of d2EGFP
expression.3570 | Lab Chip, 2015, 15, 3561–3571Data acquisition and quantitative image analysis
Live-cell imaging was performed on a motorized inverted
microscope (Nikon, Eclipse Ti-E) equipped with an objective
lens (CFI PlanFluor DL-10×, Phase1, N.A. 0.30; Nikon) and
with a temperature-controlled mounting frame for the micro-
scope stage. We used an ibidi heating system (Ibidi GmbH,
Germany) with a temperature controller to stabilize the tem-
perature of the samples at 37 °C (±2 °C) throughout the mea-
surements. To acquire cell images, we used a cooled CCD
camera (CLARA-E, Andor). A mercury light source (C-HGFIE
Intensilight, Nikon) was used for illumination and a filter
cube with the filter set 41 024 (Chroma Technology Corp.,
BP450-490, FT510, LP510-565) was used for d2EGFP detec-
tion. An illumination shutter control was used to prevent
bleaching. Images were taken at 10 fold magnification with a
constant exposure time of 600 ms at 10 minute-intervals for
at least 25 hours post-transfection. Fluorescence images were
consolidated into single-image sequence files. Quantitative
analysis of characteristic parameters of single-cell expression
kinetics allows the comparison of various vector perfor-
mances in terms of expression efficiency and stability. Image
analysis consisted of several steps and was done using in-
house-developed software based on ImageJ. First, a rectangu-
lar grid was overlaid with the original time-lapse movie and
adjusted to the size and orientation of the underlying cell-
pattern. Next, the software automatically detected d2EGFP-
expressing cells by reading out the fluorescence intensities of
all squares. Unoccupied squares were used for background
correction. The software calculates the cells' fluorescence
over the entire sequence and connects corresponding intensi-
ties to time courses of the fluorescence per cell. Finally,
single-cell fluorescence intensities per square were extracted.
Data were then analyzed as described recently by fitting
each time-course with the analytical solution for mRNA-
induced protein expression (see eqn (1)) using IgorPro soft-




A schematic representation of the underlying simplistic
model assumed for mRNA-induced protein expression is
depicted in Fig. 3C.
Conclusions
Single-cell micro-arrays present themselves as a highly paral-
lel and standardized tool for rapid transfection and quantita-
tion of mRNA expression kinetics in a much shorter time
frame compared to the conventional, population-based
molecular biological measurements. The resulting data at the
single-cell level are in good correlation with those measuredThis journal is © The Royal Society of Chemistry 2015






























































































View Article Onlinewith quantitative real-time and FC analysis. As such, this work
represents an advance in automated assessment and predic-
tive modeling of mRNA structures with respect to their expres-
sion kinetics and functional stability at the single-cell level.
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